Expected annual novel active substance launches (upper bound)
Upper bound of the projected average annual number of novel active substance launches over the next five years.
Unit Count Industry Pharmaceuticals
The chart
By region
Each region's latest published value. Periods differ where publishers release on different schedules; the period sits under each name.
Expected annual novel active substance launches (upper bound) by region
Latest value per region, 2026–2030
Forecast
View the underlying data
| Category | Source | Type | Value |
|---|---|---|---|
| Global | IQVIA | Forecast | 80 |
| United States | IQVIA | Forecast | 55 |
Every record
All records
2 records · 2 regions · 2026–2030
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global R&D Trends 2026 | IQVIA | — | 1 |
| U.S. Medicine Use Trends 2026 | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Expected annual novel active substance launches (upper bound). Retrieved from https://statorigin.org/indicators/expected-annual-novel-active-substance-launches-upper-bound